Rifaximin monotherapy was effective in patients with newly diagnosed Crohn's disease

被引：0
|
作者：
Shafran, Ira [1 ]
Burgunder, P. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-00611
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
611
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [21] Outcome of enteral feeding for newly diagnosed Crohn's disease
    Ali, E
    Crouchman, P
    Meadows, N
    Sanderson, IR
    Croft, NM
    GUT, 2002, 50 : A71 - A72
  • [22] Infliximab use in newly diagnosed children with Crohn's disease
    Rosh, JR
    Hyams, J
    Markowitz, J
    Lerer, T
    Mack, D
    Pfefferkorn, M
    Bousvaros, A
    Del Rosario, JF
    Evans, J
    Grand, R
    Griffiths, A
    Katz, A
    Kugathasan, S
    Mezoff, A
    Oliva-Hemker, M
    Otley, A
    Rothbaum, R
    Tolia, V
    Wyllie, R
    Moyer, S
    LeLeiko, N
    GASTROENTEROLOGY, 2005, 128 (04) : A39 - A39
  • [23] A watchful waiting approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype
    Sharif Yassin
    Naomi Fliss Isakov
    Yulia Ron
    Nathaniel Aviv Cohen
    Ayal Hirsch
    Nitsan Maharshak
    International Journal of Colorectal Disease, 2021, 36 : 735 - 743
  • [24] Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease
    Kowalska-Duplaga, Kinga
    Gosiewski, Tomasz
    Kapusta, Przemyslaw
    Sroka-Oleksiak, Agnieszka
    Wedrychowicz, Andrzej
    Pieczarkowski, Stanislaw
    Ludwig-Slomczynska, Agnieszka H.
    Wolkow, Pawel P.
    Fyderek, Krzysztof
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [25] A watchful waiting approach for newly diagnosed Crohn's disease patients with an inflammatory phenotype
    Yassin, Sharif
    Isakov, Naomi Fliss
    Ron, Yulia
    Cohen, Nathaniel Aviv
    Hirsch, Ayal
    Maharshak, Nitsan
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (04) : 735 - 743
  • [26] Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn’s disease
    Kinga Kowalska-Duplaga
    Tomasz Gosiewski
    Przemysław Kapusta
    Agnieszka Sroka-Oleksiak
    Andrzej Wędrychowicz
    Stanisław Pieczarkowski
    Agnieszka H. Ludwig-Słomczyńska
    Paweł P. Wołkow
    Krzysztof Fyderek
    Scientific Reports, 9
  • [27] TOFACITINIB IS SAFE AND EFFECTIVE AS MONOTHERAPY OR IN COMBINATION WITH BIOLOGIC THERAPY IN PATIENTS WITH CROHN'S DISEASE
    Clark-Snustad, Kindra D.
    Singla, Anand
    Harper, Jason
    Barahimi, Mitra
    Lee, Scott D.
    GASTROENTEROLOGY, 2020, 158 (06) : S1208 - S1209
  • [28] Disability in newly diagnosed patients with Crohn′s Disease: initial results from the prospective CROCO (Crohn′s Disease Cohort) Study
    Tinoco da Silva Torres, J.
    Ellul, P.
    Vieujean, S.
    Ordas, I.
    Burisch, J.
    Mocanu, I.
    Duricova, D.
    Rodriguez-Lago, I.
    Buisson, A.
    Goldis, A.
    Hernandez, V.
    Arebi, N.
    Kaimakliotis, I.
    Nachury, M.
    Fumery, M.
    Allocca, M.
    Pedersen, N.
    Barberio, B.
    Shaji, S.
    Guedes, A.
    Ribeiro, R.
    Ungaro, R.
    Lambert, J.
    Colombel, J. F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 443 - 444
  • [29] Use of Exclusive Enteral Nutrition Is Just as Effective as Corticosteroids in Newly Diagnosed Pediatric Crohn’s Disease
    Jason Soo
    Bushra A. Malik
    Justine M. Turner
    Rabin Persad
    Eytan Wine
    Kerry Siminoski
    Hien Q. Huynh
    Digestive Diseases and Sciences, 2013, 58 : 3584 - 3591
  • [30] Use of Exclusive Enteral Nutrition Is Just as Effective as Corticosteroids in Newly Diagnosed Pediatric Crohn's Disease
    Soo, Jason
    Malik, Bushra A.
    Turner, Justine M.
    Persad, Rabin
    Wine, Eytan
    Siminoski, Kerry
    Huynh, Hien Q.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (12) : 3584 - 3591
12345